Great Valley Advisor Group Inc. Buys 555 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Great Valley Advisor Group Inc. lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 40,962 shares of the healthcare conglomerate’s stock after buying an additional 555 shares during the period. Great Valley Advisor Group Inc.’s holdings in UnitedHealth Group were worth $23,949,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Tealwood Asset Management Inc. acquired a new stake in UnitedHealth Group during the 3rd quarter worth about $2,905,000. Asset Planning Services Inc. LA ADV lifted its stake in UnitedHealth Group by 1.2% during the 3rd quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock valued at $7,288,000 after acquiring an additional 150 shares during the period. Sequoia Financial Advisors LLC increased its stake in shares of UnitedHealth Group by 13.7% in the third quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock worth $14,603,000 after acquiring an additional 3,006 shares during the period. Americana Partners LLC boosted its holdings in UnitedHealth Group by 10.8% in the third quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate’s stock valued at $11,914,000 after purchasing an additional 1,984 shares during the last quarter. Finally, Hennion & Walsh Asset Management Inc. raised its stake in shares of UnitedHealth Group by 14.8% during the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 9,960 shares of the healthcare conglomerate’s stock valued at $5,072,000 after buying an additional 1,283 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $590.77 on Friday. The business’s fifty day moving average price is $582.63 and its 200 day moving average price is $552.59. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The firm has a market capitalization of $543.67 billion, a PE ratio of 38.49, a price-to-earnings-growth ratio of 1.75 and a beta of 0.58. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the prior year, the firm earned $6.56 EPS. The business’s revenue was up 9.2% on a year-over-year basis. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on UNH. StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday. KeyCorp assumed coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective for the company. TD Cowen lifted their price target on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. HSBC downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, Royal Bank of Canada dropped their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.